ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy tested for patients with aggressive blood cancers
Disease control Recruiting nowThis is an early safety study testing a new CAR-T cell therapy called LV009 for adults with certain blood cancers (like non-Hodgkin lymphoma or acute lymphoblastic leukemia) that have come back or not responded to other treatments. The main goals are to find a safe dose and see h…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT
Phase: EARLY_PHASE1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for High-Risk transplant patients
Disease control Recruiting nowThis early study is testing if a drug called Darzalex Faspro can safely lower harmful antibodies in patients with blood cancers. Lowering these antibodies may allow patients who are currently ineligible to receive a potentially life-saving stem cell transplant from a donor. The s…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT
Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC